That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19

Remdesivir is a nucleoside antiviral recently studied in several randomized trials for treatment of COVID-19. The available observational and prospective data are conflicting, requiring clinicians to critically evaluate and reconcile results to determine patient populations that may optimally benefi...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Matthew R., McCreary, Erin K., Pogue, Jason M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348566/
https://www.ncbi.nlm.nih.gov/pubmed/32651941
http://dx.doi.org/10.1007/s40121-020-00318-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348566/
https://www.ncbi.nlm.nih.gov/pubmed/32651941
http://dx.doi.org/10.1007/s40121-020-00318-1

Ejemplares similares